8,8'-(((ethene-1,2-diyl)bis(3-sulfo-4,1-phenylene))bis(diazene-2,1-diyl))bis(5-aminonaphthalene-2-sulfonic acid)sodium

ID: ALA5269877

Chembl Id: CHEMBL5269877

Max Phase: Preclinical

Molecular Formula: C34H27N6NaO12S4

Molecular Weight: 838.88

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(/N=N/c2ccc(/C=C/c3ccc(/N=N/c4ccc(N)c5ccc(S(=O)(=O)O)cc45)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)c2cc(S(=O)(=O)O)ccc12.[NaH]

Standard InChI:  InChI=1S/C34H26N6O12S4.Na.H/c35-29-11-13-31(27-17-23(53(41,42)43)7-9-25(27)29)39-37-21-5-3-19(33(15-21)55(47,48)49)1-2-20-4-6-22(16-34(20)56(50,51)52)38-40-32-14-12-30(36)26-10-8-24(18-28(26)32)54(44,45)46;;/h1-18H,35-36H2,(H,41,42,43)(H,44,45,46)(H,47,48,49)(H,50,51,52);;/b2-1+,39-37+,40-38+;;

Standard InChI Key:  DXMXZCHPIBYHHS-BKNXFVSTSA-N

Associated Targets(Human)

SENP1 Tchem Sentrin-specific protease 1 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SENP2 Tchem Sentrin-specific protease 2 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SENP3 Tbio Sentrin-specific protease 3 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 838.88Molecular Weight (Monoisotopic): 838.0492AlogP: 7.15#Rotatable Bonds: 10
Polar Surface Area: 318.96Molecular Species: ACIDHBA: 14HBD: 6
#RO5 Violations: 4HBA (Lipinski): 18HBD (Lipinski): 8#RO5 Violations (Lipinski): 4
CX Acidic pKa: -3.43CX Basic pKa: 2.67CX LogP: 1.99CX LogD: -3.33
Aromatic Rings: 6Heavy Atoms: 56QED Weighted: 0.03Np Likeness Score: -0.32

References

1. Wei J, Wang H, Zheng Q, Zhang J, Chen Z, Wang J, Ouyang L, Wang Y..  (2022)  Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.,  241  [PMID:35939992] [10.1016/j.ejmech.2022.114650]

Source